The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Severine Vermeire

Department of Gastroenterology

University Hospital Gasthuisberg

Herestraat 49

3000 Leuven

Belgium;

[email]@uz.kuleuven.ac.be

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium;. 2011
  • Gastroenterology Department, University Hospitals Leuven, Leuven, Belgium. 2005 - 2011
  • University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. 2004 - 2010

References

  1. The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study. Vermeire, S., Ghosh, S., Panes, J., Dahlerup, J.F., Luegering, A., Sirotiakova, J., Strauch, U., Burgess, G., Spanton, J., Martin, S.W., Niezychowski, W. Gut (2011) [Pubmed]
  2. To what extent are genetics clinically useful? Vermeire, S. Best. Pract. Res. Clin. Gastroenterol (2011) [Pubmed]
  3. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Vermeire, S., Schreiber, S., Sandborn, W.J., Dubois, C., Rutgeerts, P. Clin. Gastroenterol. Hepatol. (2010) [Pubmed]
  4. Serum sickness, encephalitis and other complications of anti-cytokine therapy. Vermeire, S., Van Assche, G., Rutgeerts, P. Best. Pract. Res. Clin. Gastroenterol (2009) [Pubmed]
  5. Genetic analysis to predict prognosis at the onset of Crohn's disease: not yet ready for prime time?. Vermeire, S., Van Assche, G., Rutgeerts, P. Gut (2009) [Pubmed]
  6. (Auto)antibodies in inflammatory bowel diseases. Vermeire, S., Vermeulen, N., Van Assche, G., Bossuyt, X., Rutgeerts, P. Gastroenterol. Clin. North Am. (2008) [Pubmed]
  7. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies. Vermeire, S., van Assche, G., Rutgeerts, P. Aliment. Pharmacol. Ther. (2007) [Pubmed]
  8. Perianal Crohn's disease: classification and clinical evaluation. Vermeire, S., Van Assche, G., Rutgeerts, P. Dig. Liver. Dis (2007) [Pubmed]
  9. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Vermeire, S., Van Assche, G., Rutgeerts, P. Gut (2006) [Pubmed]
  10. The changing face of treatment for Crohn's disease. Vermeire, S., Rutgeerts, P. Br. J. Surg (2006) [Pubmed]
  11. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Vermeire, S. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  12. The use of immunosuppressive drugs in IBD: RAND or random choice?. Vermeire, S. Dig. Liver. Dis (2005) [Pubmed]
  13. Current status of genetics research in inflammatory bowel disease. Vermeire, S., Rutgeerts, P. Genes Immun. (2005) [Pubmed]
  14. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Vermeire, S., Van Assche, G., Rutgeerts, P. Nature Clinical Practice. Gastroenterology & Hepatology (2005) [Pubmed]
  15. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Vermeire, S., Pierik, M., Hlavaty, T., Claessens, G., van Schuerbeeck, N., Joossens, S., Ferrante, M., Henckaerts, L., Bueno de Mesquita, M., Vlietinck, R., Rutgeerts, P. Gastroenterology (2005) [Pubmed]
  16. NOD2/CARD15: relevance in clinical practice. Vermeire, S. Best. Pract. Res. Clin. Gastroenterol (2004) [Pubmed]
 
WikiGenes - Universities